116308-57-7 Usage
Derivative of acetoacetic acid
2-(4-dimethylaminophenyl)ethyl acetoacetate is a derivative of acetoacetic acid, meaning it is a compound that has been chemically modified from acetoacetic acid.
Contains a dimethylamino group
The compound contains a dimethylamino group (-N(CH3)2) attached to a phenyl ring, which contributes to its chemical properties and reactivity.
Commonly used in organic synthesis
2-(4-dimethylaminophenyl)ethyl acetoacetate is commonly used as a starting material in organic synthesis for the preparation of various heterocyclic compounds and pharmaceutical intermediates.
Studied for potential biological activities
2-(4-dimethylaminophenyl)ethyl acetoacetate has been studied for its potential biological activities, including its antifungal and antioxidant properties.
Investigated for potential use in optical applications
2-(4-dimethylaminophenyl)ethyl acetoacetate has been investigated for its potential use in optical applications, such as a component of photoactive materials.
Check Digit Verification of cas no
The CAS Registry Mumber 116308-57-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,6,3,0 and 8 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 116308-57:
(8*1)+(7*1)+(6*6)+(5*3)+(4*0)+(3*8)+(2*5)+(1*7)=107
107 % 10 = 7
So 116308-57-7 is a valid CAS Registry Number.
116308-57-7Relevant academic research and scientific papers
DIHYDROPYRIDINE DERIVATIVES AND PHARMACEUTICALS COMPOSITION THEREOF
-
, (2008/06/13)
Dihydropyridine derivatives of the formula wherein R1, R2, R3, R4, R5, A, B are defined as in the specification and nontoxic acid-addition salts thereof, have an excellent calcium blocking action (Ca-antagonist), and antihypertensive action, a platelet aggregation inhibiting action, a phosphodiesterase-inhibiting action and the like, and thus are useful as a medicine, such as a coronary vasocilator, a cerebral hyperkinemic, antihypertensive, thrombosis-preventing or treating agents, phosphodiesterase inhibitor or the like. Pharmaceutical compositions and methods of use are also disclosed
